The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,165.00
Bid: 1,159.00
Ask: 1,173.00
Change: -11.00 (-0.94%)
Spread: 14.00 (1.208%)
Open: 1,200.00
High: 1,200.00
Low: 1,160.00
Prev. Close: 1,176.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

3 Jul 2014 07:00

RNS Number : 2876L
Burford Capital
03 July 2014
 



3 July 2014

BURFORD CAPITAL CONTINUES STRONG PERFORMANCE

 

Investment returns rise to 63% on invested capital

 

Burford Capital Limited ("Burford"), the world's largest provider of investment capital and risk solutions for litigation, intends to release its interim financial statements for the six months ended 30 June 2014 on 4 September 2014.

 

In advance of that release, Burford provides the following performance update for the six month period ended 30 June 2014 (the "period"):

 

· Continued strong investment returns: Since inception, 26 investments have generated $173.9 million in gross investment recoveries and $67 million net of invested capital, producing a 63% net return on invested capital1

 

o This represents a 67% increase, $27 million, over the net position at 30 June 2013

 

· Material increase in cash generation: Burford generated $41.9 million of cash from the investment portfolio in the period, an increase of 94% over the comparable 2013 period

 

· Ongoing demand for Burford's capital reflected in $62 million of new capital committed in the period, a five-fold increase over the comparable 2013 period

 

· Successful completion of an innovative financing transaction with Rurelec PLC, a publicly-traded power generation company, that provided recourse financing linked to an arbitration claim, which provided an $11 million profit to Burford (a 73% return and a 34% IRR) while providing Rurelec with expansion capital

 

Christopher Bogart, Burford's CEO, commented: "Burford's performance continues to vindicate our approach to investment selection and the quality of our team. Moreover, the volume of new commitments made during the last six months shows clearly the market demand for litigation finance solutions - and the success of the Rurelec transaction we announced last month shows our continued market leadership in innovating to meet that demand."

 

1 Term definitions and computation methodology are as set forth in Burford's 2013 annual report.

For further information, please contact:

 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

 

Espirito Santo Investment Bank - Joint Broker

John Llewellyn-Lloyd +44 (0)20 7456 9191

Harry Stockdale

 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0)20 7653 4000

 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 3727 1046

Laura Ewart +44 (0)20 3727 1160

 

About Burford Capital

 

Burford Capital is the world's largest provider of investment capital and risk solutions for litigation with the largest and most experienced dedicated team in the industry. Burford is publicly traded on the London Stock Exchange's AIM market under the ticker symbol BUR. Burford provides a broad range of corporate finance and insurance solutions to lawyers and clients engaged in significant litigation and arbitration around the world.

 

For more information about Burford, visit www.burfordcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAKXAEDFLEFF
Date   Source Headline
13th May 202412:00 pmRNS1Q24 Results & Quarterly Report
9th May 20247:00 amRNSNotice of 1Q24 Results & Results Call Details
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.